- Home
- ADPT vs VTS Comparison
ADPT vs VTS Comparison
Compare ADPT & VTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- VTS
- Stock Information
- Founded
- ADPT 2009
- VTS 2014
- Country
- ADPT United States
- VTS United States
- Employees
- ADPT N/A
- VTS N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- VTS Oil & Gas Production
- Sector
- ADPT Health Care
- VTS Energy
- Exchange
- ADPT Nasdaq
- VTS Nasdaq
- Market Cap
- ADPT 929.8M
- VTS 798.6M
- IPO Year
- ADPT 2019
- VTS N/A
- Fundamental
- Price
- ADPT $5.94
- VTS $25.78
- Analyst Decision
- ADPT Buy
- VTS Strong Buy
- Analyst Count
- ADPT 4
- VTS 1
- Target Price
- ADPT $6.50
- VTS $29.00
- AVG Volume (30 Days)
- ADPT 1.4M
- VTS 141.6K
- Earning Date
- ADPT 02-12-2025
- VTS 11-04-2024
- Dividend Yield
- ADPT N/A
- VTS 8.09%
- EPS Growth
- ADPT N/A
- VTS N/A
- EPS
- ADPT N/A
- VTS 1.45
- Revenue
- ADPT $177,282,000.00
- VTS $232,520,000.00
- Revenue This Year
- ADPT $6.48
- VTS $19.53
- Revenue Next Year
- ADPT $18.84
- VTS $0.87
- P/E Ratio
- ADPT N/A
- VTS $17.95
- Revenue Growth
- ADPT N/A
- VTS 13.53
- 52 Week Low
- ADPT $2.28
- VTS $19.63
- 52 Week High
- ADPT $7.07
- VTS $28.41
- Technical
- Relative Strength Index (RSI)
- ADPT 61.49
- VTS 34.62
- Support Level
- ADPT $5.98
- VTS $27.00
- Resistance Level
- ADPT $6.93
- VTS $27.89
- Average True Range (ATR)
- ADPT 0.45
- VTS 0.61
- MACD
- ADPT 0.03
- VTS -0.28
- Stochastic Oscillator
- ADPT 75.53
- VTS 0.00
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.